Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

Nature - 19 Sept 1991

Rubin E M, Krauss R M, Spangler E A, Verstuyft J G, Clift S M

Abstract excerpt

Epidemiological surveys have identified a strong inverse relationship between the amount in the plasma of high density lipoproteins (HDL), apolipoprotein AI (ApoA-I), the major protein component of HDL, and the risk for atherosclerosis in humans. It is not known if this relationship arises from a direct antiatherogenic effect of these plasma components or if it is the result of other factors also associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoproteins A
Share to Arteriosclerosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Mice, Inbred C57BL

Share to Mice, Transgenic

Share to Muscle, Smooth, Vascular

Source

Identifiers

PMID: 1910153
DOI: 10.1038/353265a0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.PMID 1910153Read ↗

Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.Semantic proximity Read ↗

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.Semantic proximity Read ↗

HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.Semantic proximity Read ↗

Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.Semantic proximity Read ↗

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.Semantic proximity Read ↗

Atherosclerosis in aged mice over-expressing the reverse cholesterol transport genes.Semantic proximity Read ↗

Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.Semantic proximity Read ↗

Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano).Semantic proximity Read ↗

Mouse models of atherosclerosis.Semantic proximity Read ↗

Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice.Semantic proximity Read ↗

Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.Semantic proximity Read ↗

Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.